These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3125744)

  • 1. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
    Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
    Hosotani H; Ohashi Y; Yamada M; Tsubota K
    Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aldose reductase inhibitor on the corneal epithelium.
    Tsubota K; Yamada M
    Cornea; 1993 Mar; 12(2):161-2. PubMed ID: 8500324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.
    Awata T; Sogo S; Yamagami Y; Yamamoto Y
    J Ocul Pharmacol; 1988; 4(3):195-201. PubMed ID: 3143793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.
    Ohashi Y; Awata T; Sogo S; Ohira M; Matsuda M; Fukuda M; Manabe R
    J Ocul Pharmacol; 1989; 5(4):325-8. PubMed ID: 2516866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
    Takahashi Y; Akagi Y; Akimune M; Tamura K; Itoi M
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.
    Nakahara M; Miyata K; Otani S; Miyai T; Nejima R; Yamagami S; Amano S
    Br J Ophthalmol; 2005 Mar; 89(3):266-8. PubMed ID: 15722300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y; Takahashi Y; Tanabe T; Ikebe H; Majima K; Miyatani H; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
    Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
    Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats.
    Yokoi N; Niiya A; Komuro A; Yokogaki S; Naka H; Awata T; Honma Y; Yamada J; Tei M; Kinoshita S
    Curr Eye Res; 1997 Jun; 16(6):595-9. PubMed ID: 9192169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
    Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.
    Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R
    Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.
    Fujishima H; Shimazaki J; Yagi Y; Tsubota K
    Cornea; 1996 Jul; 15(4):368-75. PubMed ID: 8776562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimentally induced diabetic retinal microangiopathy and polyol pathway. II. Effect of aldose reductase inhibitors on microangiopathy].
    Kojima K; Matsubara H; Mizuno K; Harada T; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):247-56. PubMed ID: 3923790
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.